GFAP and Alzheimer disease: The density plots show that the combination of P‐tau181, GFAP and age‐corrected NfL when interpreted in aggregation performs well to differentiate Aβ− from Aβ+ in the total cohort and in the SCD and MCI subset and to discriminate FTD from AD or from controls.